The Impact of the COVID-19 Pandemic on Breast and Cervical Cancer Screening: A Systematic Review

In Vivo, Journal Year: 2023, Volume and Issue: 37(4), P. 1455 - 1476

Published: Jan. 1, 2023

Background/Aim: COVID-19 has dramatically impacted non-pandemic-related care, including preventive medicine. Our objective was to quantify the alterations in volume of screening tests for breast and cervical cancer during era compared pre-pandemic levels. Secondarily, we discussed causes responsible this change, presented suggestions optimization conducted a targeted search relevant literature worsening future mortality due setback. Materials Methods: We systematically searched Pubmed, Google Scholar Epistemonikos articles English or Greek, published from March 11th, 2020, until September 14th, 2022, that illustrated quantitative variations mammograms Pap/HPV tests. Preprint articles, editorials speeches were excluded. Quality included studies assessed via JBI critical appraisal checklist reporting prevalence data. The evidence narratively synthesized. Results: A total 56 included, being either observational reports registries. Large reductions universally identified, peaked first wave but partially persisted after easing restrictions. Conclusion: systematic review provides an updated record approaches neglect multidimensional perspective answering why it happened how could achieve recovery. strong awareness campaign is proposed, conjunction with triaging citizens more likely benefit screening. Cervical self-sampling emphasized literature. Various displayed potential increase based on predictive statistical models.

Language: Английский

---

The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: March 27, 2024

Introduction The COVID-19 pandemic had collateral effects on many health systems. Cancer screening and diagnostic tests were postponed, resulting in delays diagnosis treatment. This study assessed the impact of screening, diagnostics incidence breast, colorectal, lung, prostate cancer; whether rates returned to pre-pandemic levels by December, 2021. Methods is a cohort electronic records from United Kingdom (UK) primary care Clinical Practice Research Datalink (CPRD) GOLD database. included individuals registered with CPRD between January, 2017 2021, at least 365 days clinical history. focused tests, referrals diagnoses first-ever cancer. Incidence (IR) stratified age, sex, region, rate ratios (IRR) calculated compare during after lockdown before lockdown. Forecasted estimated using negative binomial regression models. Results Among 5,191,650 eligible participants, first resulted reduced for all cancers, which remained dramatically across whole observation period almost investigated. There significant IRR reductions breast (0.69 [95% CI: 0.63-0.74]), colorectal (0.74 0.67-0.81]), (0.71 0.66-0.78]) cancer diagnoses. lung non-significant (0.92 0.84-1.01]). Extrapolating entire UK population, an 18,000 13,000 10,000 21,000 missed March, 2020 Discussion substantial referrals, significantly lower than cancers associated Delays are likely have adverse consequences stage, treatment initiation, mortality rates, years life lost. Urgent strategies needed identify undiagnosed cases address long-term implications delayed

Language: Английский

---

New Cancer Diagnoses Before and During the COVID-19 Pandemic

JAMA Network Open, Journal Year: 2023, Volume and Issue: 6(9), P. e2332363 - e2332363

Published: Sept. 5, 2023

Disruptions to health care during the COVID-19 pandemic may have led missed cancer diagnoses. It is critical evaluate association between and incidence address public patient anxiety, inform recovery efforts, identify strategies reduce system's vulnerability future disruptions.To examine in Manitoba, Canada.A population-based cross-sectional study design was conducted using data from Manitoba Cancer Registry an interrupted time-series analysis. All individuals diagnosed with Canada, January 1, 2015, until December 31, 2021, were included. Individuals breast, colon, rectal, or lung grouped by age as follows: younger than 50 years, 74 75 years older.COVID-19 pandemic.Age-standardized rates estimated cumulative difference number of cases absence observed (fitted) cases.A total 48 378 The median (IQR) at diagnosis 68 (59-77) 23 972 participants (49.6%) female. In April 2020, there a 23% decrease overall incidence. decreased 46% for 35% 47% 50% head neck, 65% melanoma, 33% endocrine diagnoses increased 12% hematological 8% cancers unknown primary site. Lung remained stable 2020 when it 11%. Brain central nervous system urinary consistently over time 2021 26% 12%, respectively. No gynecologic (1% increase), other digestive decrease), pancreatic (7% increase) As had deficit 692 (5.3%) cancers. largest deficits breast (273 cases, 14.1% deficit), colon (133 12.2% (132 7.6% deficit).In this study, associated initial followed most sites. However, some high fatality needs immediate attention.

Language: Английский

---

Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals

eLife, Journal Year: 2023, Volume and Issue: 12

Published: June 28, 2023

Background: The coronavirus disease 2019 (COVID-19) pandemic has caused disruptions to cancer care by delaying diagnoses and treatment, presenting challenges uncertainties for both patients physicians. We conducted a nationwide online survey investigate the effects of capture modifications, prompted pandemic-related control measures, on cervical screening-related activities from mid-March mid-August 2020, across Canada. Methods: consisted 61 questions related continuum in screening treatment: appointment scheduling, tests, colposcopy, follow-up, treatment pre-cancerous lesions/cancer, telemedicine. piloted with 21 Canadian experts prevention care. partnered Society Colposcopists, Gynecologic Oncology Canada, Association Pathologists, Obstetricians Gynecologists which distributed their members via email. reached out family physicians nurse practitioners MDBriefCase. was also posted McGill Channels (Department Family Medicine News Events) social media platforms. data were analyzed descriptively. Results: Unique responses collected 510 participants (November 16, February 28, 2021), representing 418 fully 92 partially completed surveys. Responses Ontario (41.0%), British Columbia (21.0%), Alberta (12.8%), mostly comprised physicians/general (43.7%), gynecologist/obstetrician professionals (21.6%). Cancelled appointments mainly reported (28.3%), followed (19.8%), primarily occurred private clinics (30.5%). Decreases number Pap tests colposcopy procedures consistently observed provinces. About 90% that practice/institution adopted telemedicine communicate patients. Conclusions: area most severely impacted an important level cancellations reported. Survey results may inform resumptions various fronts management. Funding: present work supported Institutes Health Research (operating grant COVID-19 May 2020 Rapid Funding Opportunity VR5-172666 competition foundation 143347 Eduardo L Franco). Eliya Farah Rami Ali each received MSc stipend Department Oncology, University.

Language: Английский

---

Impact of COVID-19 on cancer screening: a global perspective

Current Opinion in Supportive and Palliative Care, Journal Year: 2022, Volume and Issue: 16(3), P. 102 - 109

Published: July 18, 2022

Purpose of review Cancer screening disruption due to COVID-19 may have a significant impact on patients, healthcare practitioners, and systems. In this present review, we aim offer comprehensive view the effect pandemic cancer programs worldwide. Recent findings The comprised 33 publications. During pandemic, rates investigations were drastically reduced Screening plummeted for all types cancer, ages, racial/ethnic groups. Reductions in percentages higher several underserved racial was suspended at least 30 days 13 countries. Summary Screenings fell sharply. chain management, delays any step are liable change outcome next step. Further long-term research will be needed fully comprehend services patient outcomes.

Language: Английский

---

Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications

Breast Cancer Targets and Therapy, Journal Year: 2023, Volume and Issue: Volume 15, P. 51 - 89

Published: Jan. 1, 2023

Abstract: During the COVID-19 pandemic, several priority diseases were not getting sufficient attention. Whilst breast cancer is a fatal disease affecting millions worldwide, identification and management of these patients did initially attract critical attention to minimize impact lockdown, post-lockdown, other measures. Breast patients' conditions may remain stable without proper care, worsening their prognosis. Proper care includes timely instigation surgery, systemic therapy, psychological support. This low-and middle-income countries where there are already concerns with available personnel medicines adequately identify treat patients. Consequently, was need summarize current scenario regarding managing during across all countries, including any guidelines developed. We systematically searched three scientific databases found 76 eligible articles covering medical strategies high-income versus LMICs. Typically, diagnostic facilities in hospitals affected at beginning pandemic following lockdown resulted more advanced-stage cancers being detected initial presentation negatively impacting patient outcomes. Other than increased telemedicine, instigating neo-adjuvant endocrine therapy often, reducing non-essential visits, increasing application chemotherapy meet challenges, encouragingly, no significant difference among Numerous evolved address challenges posed by lockdowns measures, which subsequently adopted various LMICs improve care. The associated especially peak waves, subsequent effect on patient's mental health must also be considered this high-priority group. will continue monitor situation provide direction future pandemics. Keywords: COVID-19, cancer, healthcare system, management, treatment, guidelines, unintended consequences

Language: Английский

---

Estimation of Oncologic Surgery Case Volume Before and After the COVID-19 Pandemic in France

JAMA Network Open, Journal Year: 2023, Volume and Issue: 6(1), P. e2253204 - e2253204

Published: Jan. 26, 2023

COVID-19 has had a major effect on health care activities, especially surgery. At first, comparisons were proposed using 2019 activities as the highest standard. However, while such an approach might have been suitable during first months of pandemic, this no longer be case for period.To examine approaches that may better assess use cancer surgeries.In cross-sectional design, nationwide French hospital facility data (Medicalised Information System Program) used to surgery 6 site categories in adults from January 1, 2010, December 31, 2021.Estimated activity pandemic.Three models expected number surgical procedures between 2020 and 2021 make comparison with those observed earlier years.In France, removal surgeries account approximately 7000 hospitalizations per year liver cancer; 4000 pancreatic 7700 ovarian 1300 esophagus 23 000 ear, nose, throat (ENT) 78 breast 16 600 thoracic cancers. For most sites, increased 2010 2019: liver, 14%; pancreas, 38%; ovary, esophagus, 18%; breast, 8%; thoracic, 29%. Assuming stability, these values underestimate gap 2020-2021. other procedures, decrease was observed: stomach, -10%, ENT, -6%. overestimate end 2021, according model, 2020-2021 estimated at -1.4% 1.7% -6.6% -7.3% -3.1% -2.5% ovarian, -4.2% -1.7% -6.7% 5.9% -13.0% -13.9% esophageal urologic cancers, because trend different before after 2015, it necessary opt modeling only recent period. The cumulative -1.0% ENT -5.3% -2.9% cancers.The findings study suggest short- medium-term trends must considered estimate activities. Breast is which showed smallest almost full recovery 2021.

Language: Английский

---

Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019–2021)

Cancers, Journal Year: 2023, Volume and Issue: 15(6), P. 1753 - 1753

Published: March 14, 2023

The coronavirus disease 2019 (COVID-19) pandemic has caused a significant disruption to cancer diagnosis, treatment and prevention worldwide that could have serious consequences in the near future. We intend evaluate weight of this backlog on community-wide scale Madrid during period 2020-2021, whether stage shift towards advanced occurred. Cancer diagnoses tumor registry (RTMAD) from 2019-2021 were evaluated. Absolute percentage differences annual volume observed-to-expected (O/E) ratios calculated. Standardized incidence (SIRs) 95% confidence intervals (CIs) calculated using O/E ratio. SIR for 2020-2021 compared was 94.5% (95% CI 93.8-95.3), with unequal gender-specific diagnosis recovery (88.5% males 102.1% females). Most types underdiagnosed 2020. tendency worsened 2021 colorectal prostate cancers (87.8%), but lung recovered (102.1%) breast over-diagnosed (114.4%) reference pre-COVID-19 data. These changes modified ranking most frequent malignancies diagnosed Madrid. Breast overtaken cancers, displaced second third position, respectively. Not only affected more as consequence COVID-19 malignancy at advance also increased by 3.6% 2020 4.2% 2019. In summary, there is large undetected reduced access care secondary pandemic, especially regarding cancer. Strategies are needed recover effectively treat these cases future solve negative impact will be diagnostic delay. Analyzing new suffered each different their help understand how allocation resources should look.

Language: Английский

---

Factors associated with delay or avoidance of medical care during the COVID-19 pandemic in Armenia: results from a nationwide survey

BMC Health Services Research, Journal Year: 2024, Volume and Issue: 24(1)

Published: Jan. 4, 2024

Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has disrupted healthcare systems throughout the world. Many patients faced delays and cancellation of care due to scaled back services, mobility restrictions, concerns related risk infection. present study aimed assess prevalence factors associated with avoidance or delay medical COVID-19 in Armenia. Methods We conducted a cross-sectional telephone survey 3,483 adults across used stratified two-stage cluster sampling select participants from different age groups proportionate their size population. Logistic regression analysis assessed association avoidance/delay routine, urgent/emergency, any care. Results mean sample was 49.5 (SD = 14.8), ranging 18 90. About 9.9% respondents avoided/delayed type care; whereas 5.5% urgent/emergency 6.6% routine In adjusted analysis, female gender higher monthly expenditures were Factors delay/avoidance included perceived threat COVID-19. Younger age, gender, not being vaccinated against analysis. Conclusion Since avoiding delaying might increase morbidity mortality conditions COVID-19, identifying population that are more likely avoid is important. Targeting such educational interventions focusing on risks using versus times be crucial. Ensuring provision in-home services for high-risk help address important needs during pandemic.

Language: Английский

---

“It’s a low-key thing of eugenics”: Disability reproductive injustice in barriers to cervical cancer screening for people with disabilities during the COVID-19 pandemic

Social Science & Medicine, Journal Year: 2025, Volume and Issue: 369, P. 117807 - 117807

Published: Feb. 3, 2025

Cervical cancer screening (CCS) is a critical component of preventative sexual and reproductive healthcare, yet there are disparities in access to CCS for people with disabilities. This qualitative community-engaged study uses the disability justice framework examine how COVID-19 pandemic impacted disabilities' experiences Canada. From May 2022 March 2023, semi-structured interviews were conducted 40 women gender-diverse physical, sensory, cognitive, and/or mental health Results from thematic analysis indicate that barriers before during characterized by inaccessibility, ableism intersecting forms oppression, provider distrust, deprioritization disregard disabled people's autonomy. Grounded these findings, this article situates healthcare like as concern. Amplified pandemic, enacted injustice through everyday micro-eugenics devalued Barriers must be addressed collaboration communities. Guided participant insights, recommendations include making services more accessible available disabilities, especially aftermath public emergencies disproportionately impact

Language: Английский

---